Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook

Front Endocrinol (Lausanne). 2022 Apr 7:13:865436. doi: 10.3389/fendo.2022.865436. eCollection 2022.

Abstract

Chemotherapy is a critical treatment for endocrine-related cancers; however, chemoresistance and disease recurrence remain a challenge. The interplay between cancer cells and the tumor microenvironment via cell adhesion molecules (CAMs) promotes drug resistance, known as cell adhesion-mediated drug resistance (CAM-DR). CAMs are cell surface molecules that facilitate cell-to-cell or cell-to-extracellular matrix binding. CAMs exert an adhesion effect and trigger intracellular signaling that regulates cancer cell stemness maintenance, survival, proliferation, metastasis, epithelial-mesenchymal transition, and drug resistance. To understand these mechanisms, this review focuses on the role of CD44, cadherins, selectins, and integrins in CAM-DR in endocrine-related cancers.

Keywords: cell adhesion molecules; cell adhesion-mediated drug resistance; chemoresistance; endocrine-related cancers; tumor microenvironment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cadherins / metabolism
  • Cadherins / pharmacology
  • Cell Adhesion
  • Cell Adhesion Molecules* / metabolism
  • Humans
  • Integrins / metabolism
  • Neoplasms*
  • Tumor Microenvironment

Substances

  • Cadherins
  • Cell Adhesion Molecules
  • Integrins